
    
      This is a Multicenter, Randomized, Double Blind, Vehicle-Controlled Study to Evaluate the
      Safety and Efficacy of 3 concentrations of Topically Applied BBI-4000 in Subjects with
      Axillary Hyperhidrosis.

      Safety will be assessed through collection of vital signs, adverse events, local skin
      responses, hematology, serum chemistry laboratory testing and urinalysis.
    
  